• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC

GlaxoSmithKline PLC

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. New Glaxo CEO Seeks Tighter Drug Focus -- WSJ

    New Glaxo CEO Seeks Tighter Drug Focus -- WSJ

  2. Glaxo's New Boss Emma Walmsley Seeks Sharper R&D Edge--Update

    Glaxo's New Boss Emma Walmsley Seeks Sharper R&D Edge--Update

  3. Innoviva Urges Shareholders to Vote “FOR” All of Innoviva’s Value-Creating Directors On the WHITE Proxy Card TODAY

    Innoviva Urges Shareholders to Vote “FOR” All of Innoviva’s Value-Creating Directors On the WHITE Proxy Card TODAY

  4. Prescription-drug Shortages Help Push Up Prices of Similar Drugs

    Prescription-drug Shortages Help Push Up Prices of Similar Drugs

  5. Antibacterial Therapies Drug Development Pipeline Review 2017 - Research and Markets

    Antibacterial Therapies Drug Development Pipeline Review 2017 - Research and Markets

  6. Cachexia - Pipeline Review, H1 2017 Featuring Aphios, GlaxoSmithKline, MYOS RENS Technology, Novartis, Teijin Pharma & VBS Pharmaceuticals - Research and Markets

    Cachexia - Pipeline Review, H1 2017 Featuring Aphios, GlaxoSmithKline, MYOS RENS Technology, Novartis, Teijin Pharma & VBS Pharmaceuticals - Research and Markets

  7. BMW, Glaxo and Allstate Join Advertisers Withdrawing From O'Reilly's Show -- Update

    BMW, Glaxo and Allstate Join Advertisers Withdrawing From O'Reilly's Show -- Update

  8. Glaxo's New CEO Is a Steady Hand in Pharmaceuticals' Rolling Seas

    Glaxo's New CEO Is a Steady Hand in Pharmaceuticals' Rolling Seas

  9. Glaxo's New Chief Steps Into the Fray -- WSJ

    Glaxo's New Chief Steps Into the Fray -- WSJ

  10. FDA nominee Scott Gottlieb plans recusals from decisions on many drug firms

    FDA nominee Scott Gottlieb plans recusals from decisions on many drug firms

12

©2017 Morningstar Advisor. All right reserved.